Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This man-made peptide resembles the actions of naturally occurring GLP-1, a https://bookmarksfocus.com/story6504057/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes